Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 16.10.2019 Börsentäglich über 12.000 News von 613 internationalen Medien
Konkurrenz beeindruckt! Bisher noch unentdeckt von Investoren ist die neue Technologie jetzt marktreif! Aktie vor Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKMZ ISIN: US6700024010 Ticker-Symbol: NVV1 
Tradegate
16.10.19
19:00 Uhr
4,300 Euro
-0,080
-1,83 %
1-Jahres-Chart
NOVAVAX INC Chart 1 Jahr
5-Tage-Chart
NOVAVAX INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,260
4,360
21:03
4,280
4,320
21:02

Aktuelle News zur NOVAVAX Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiNovavax, Inc.: Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults184First participants enrolled in pivotal Phase 3 clinical trial of NanoFlu Top-line clinical data expected in the first quarter of 2020 Phase 3 results expected to support a future BLA and licensure of...
► Artikel lesen
24.09.Novavax, Inc. (NVAX) Management Presents at Ladenburg Thalmann 2019 Healthcare Conference (Transcript)22
NOVAVAX Aktien jetzt im kostenlosen Demokonto handeln!
19.09.Novavax, Inc.: Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference685GAITHERSBURG, Md., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...
► Artikel lesen
10.09.Novavax, Inc. (NVAX) presents at H.C. Wainwright 21st Annual Global Investment Conference (Transcript)22
09.09.NOVAVAX INC - 8-K, Current Report7
06.09.Novavax, Inc.: Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference671GAITHERSBURG, Md., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...
► Artikel lesen
16.08.CARA, OSTK, SA and NVAX among notable after hours movers20
16.08.Why Novavax Stock Is Soaring Today45
14.08.Options Traders Take Chance on NVAX Stock After Big Analyst Call39
14.08.Novavax adds to ResVax-stoked rally, shares ahead 36%38
14.08.Novavax and Akari Therapeutics among healthcare gainers; DelMar Pharmaceuticals leads the losers32
12.08.Novavax up 7% on new ResVax data13
12.08.Novavax, Inc.: New Data from Novavax Phase 3 Prepare Trial of ResVax Presented at 2019 IDSOG Annual Meeting657Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of lifeGAITHERSBURG, Md., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage...
► Artikel lesen
10.08.Novavax, Inc. (NVAX) CEO Stan Erck on Q2 2019 Results - Earnings Call Transcript6
08.08.NOVAVAX INC - S-8, Securities to be offered to employees in employee benefit plans1
08.08.NOVAVAX INC - 8-K, Current Report1
08.08.Novavax, Inc.: Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting461GAITHERSBURG, Md., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...
► Artikel lesen
07.08.EARNINGS SUMMARY: Details of Novavax Inc. Q2 Earnings Report5
07.08.NOVAVAX INC - 10-Q, Quaterly Report-
07.08.Novavax, Inc.: Novavax Reports Second Quarter 2019 Financial Results400Agreement with the FDA on Phase 3 non-inferiority immunogenicity study design for NanoFluNanoFlu pivotal Phase 3 clinical trial expected to initiate in the third quarter of 2019 with top-line data in...
► Artikel lesen
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
3,1,1